Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia-Reference-Cited by-同舟云学术

Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia

Published:2018-09 Issue:3 Volume:52 Page:350-357
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Khoo Ai Leng,Zhao Ying Jiao,Teng Monica,Ying Ding,Jin Jing,Chee Yen Lin,Poon Li Mei,Lim Siew Eng,Koh Liang Piu,Chng Wee Joo,Lim Boon Peng,Hsu Li Yang,Chai Louis Yi Ann

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011

2. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia;Averbuch;Haematologica,2013

3. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital;Poon;Singapore Med J,2012

4. Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994–1996) [in Spanish];Figuera;Med Clin (Barc),2001

5. Piperacillin–tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital;Oztoprak;Jpn J Clin Oncol,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftazidime-Avibactam for the Treatment of Febrile Neutropenia in HSCT Recipients and Acute Leukemia Patients Post Induction Chemotherapy;2024-07-01

2. Evaluating the use of meropenem in hematologic patients with febrile neutropenia;Mediterranean Journal of Hematology and Infectious Diseases;2023-10-30

3. Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study;European Journal of Clinical Microbiology & Infectious Diseases;2021-01-03

4. Evaluation of Risk Factors for Mortality in Febrile Neutropenia;The Journal of Infection in Developing Countries;2020-08-31

5. Real-time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: results from a prospective, monocentric, interventional study;Journal of Antimicrobial Chemotherapy;2020-07-18